Evidence map›Paper›PMID 16387805›Full record

ArticleAmerican journal of respiratory and critical care medicine2006

Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice.

Robert F Foronjy, Oleg Mirochnitchenko, Olga Propokenko, Vincent Lemaitre, Yuxia Jia, Masayori Inouye, Yasunori Okada, Jeanine M D'Armiento

Abstract readComparative Study
In one paragraph

Article in American journal of respiratory and critical care medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 144 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Oxidative Stress in Chronic Obstructive Pulmonary Disease.Antioxidants (Basel, Switzerland) · 2022
    Review
  5. Article
  6. Loss of FCHSD1 leads to amelioration of chronic obstructive pulmonary disease.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. Alpha-1 Antitrypsin Deficiency: Have We Got the Right Proteinase?Chronic obstructive pulmonary diseases (Miami, Fla.) · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Robert F ForonjyDepartment of Medicine, Columbia University, 630 West 168th Street, P&S 8-401, New York, NY 10032, USA.
Oleg Mirochnitchenko
Olga Propokenko
Vincent Lemaitre
Yuxia Jia
Masayori Inouye
Yasunori Okada
Jeanine M D'Armiento
Keio University · JPColumbia University · US

Funding

The Effects of PP2A on TNF Signaling and Smoke-Induced Lung InjuryR01HL098528 · NHLBI · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI FORONJY, ROBERT F · 2010 to 2014
$2.2M
NHLBI NIH HHS L30 HL074905NHLBI NIH HHS R01 HL098528
6 · The paper itself

Abstract

rationaleOxidants are believed to play a major role in the development of emphysema.

objectivesThis study aimed to determine if the expression of human copper-zinc superoxide dismutase (CuZnSOD) within the lungs of mice protects against the development of emphysema.

methodsTransgenic CuZnSOD and littermate mice were exposed to cigarette smoke (6 h/d, 5 d/wk, for 1 yr) and compared with nonexposed mice. A second group was treated with intratracheal elastase to induce emphysema. MEASUREMENTS: Lung inflammation was measured by cell counts and myeloperoxidase levels. Oxidative damage was assessed by immunofluorescence for 3-nitrotyrosine and 8-hydroxydeoxyguanosine and lipid peroxidation levels. The development of emphysema was determined by measuring the mean linear intercept (Lm). MAIN

resultsSmoke exposure caused a fourfold increase in neutrophilic inflammation and doubled lung myeloperoxidase activity. This inflammatory response did not occur in the smoke-exposed CuZnSOD mice. Similarly, CuZnSOD expression prevented the 58% increase in lung lipid peroxidation products that occurred after smoke exposure. Most important, CuZnSOD prevented the onset of emphysema in both the smoke-induced model (Lm, 68 exposed control vs. 58 exposed transgenic; p < 0.04) and elastase-generated model (Lm, 80 exposed control vs. 63 exposed transgenic; p < 0.03). These results demonstrate for the first time that antioxidants can prevent smoke-induced inflammation and can counteract the proteolytic cascade that leads to emphysema formation in two separate animal models of the disease.

conclusionsThese findings indicate that strategies aimed at enhancing or supplementing lung antioxidants could be effective for the prevention and treatment of this disease.

Indexed as

SmokingAnimalsBiomarkersCell CountDisease Models, AnimalDisease ProgressionLipid PeroxidationLungMacrophages, AlveolarMiceMice, Inbred C57BLPancreatic ElastasePeroxidasePulmonary EmphysemaSuperoxide DismutaseBiomarkersPancreatic ElastasePeroxidaseSuperoxide Dismutase

Identifiers

PMID16387805
PMCPMC3982860
OpenAlexW2157167353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.